Drug-resistant tuberculosis: time for visionary political leadership

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Andrew Siroka, BS, Ninez A Ponce, PhD, Knut Lönnroth, MD

Tropical Diseases Infectious Disease Clinics

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration Alasdair Reid, MD, Fabio Scano,

Optimisation of infection prevention and control in acute health care by use of behaviour change: a systematic review Rachel Edwards, MSc, Esmita Charani,

Global implementation of WHO's multimodal strategy for improvement of hand hygiene: a quasi-experimental study Benedetta Allegranzi, MD, Angèle Gayet-Ageron,

Volume 387, Issue 10033, Pages (May 2016)

Antimicrobial therapy to prevent or treat oral mucositis

Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? Dr Simone Lanini, MD, Prof Alimuddin.

Volume 383, Issue 9920, Pages (March 2014)

Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis Katharina Kranzer,

Helen Cox, Mark P Nicol The Lancet Infectious Diseases

Volume 9, Issue 5, Pages (May 2008)

Volume 390, Issue 10092, Pages (July 2017)

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage.

Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study Matthew Waxman, MD,

When less is more: how many doses of PCV are enough?

Volume 389, Issue 10071, Pages (February 2017)

Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive.

Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data Caroline L Trotter, PhD, Clément Lingani,

Volume 390, Issue 10092, Pages (July 2017)

The Gobi Desert medical kit

Volume 382, Issue 9895, Pages (September 2013)

Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based.

Volume 383, Issue 9920, Pages (March 2014)

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment Sven O Friedrich,

Medical education and research in Pakistan

Rebalancing the global battle against tuberculosis

Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis Manish Pareek, MRCP, John.

The effect of explosive remnants of war on global public health: a systematic mixed- studies review using narrative synthesis Alexandra Frost, MSc, Prof.

Emerging resistant clone of Mycobacterium tuberculosis in west Asia

Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? Dr Simone Lanini, MD, Prof Alimuddin.

Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts Ben J Marais, FCPaed, Knut.

Alcohol use among young adolescents in low-income and middle-income countries: a population-based study Chuanwei Ma, MSc, Pascal Bovet, MD, Lili Yang,

Volume 379, Issue 9835, Pages (June 2012)

Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis Ulla Beijer, PhD, Achim Wolf, MSc, Dr.

Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing Dr.

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

Volume 6, Issue 4, Pages (April 2019)

Volume 392, Issue 10164, Pages (December 2018)

Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.

Percentage of previously treated tuberculosis (TB) cases with multidrug-resistant (MDR)-TB. Percentage of previously treated tuberculosis (TB) cases with.

Global implementation of WHO's multimodal strategy for improvement of hand hygiene: a quasi-experimental study Benedetta Allegranzi, MD, Angèle Gayet-Ageron,

Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis Dr Robert W Aldridge, MSc,

Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England.

Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis Prof Peter Collignon,

Volume 2, Issue 6, Pages e243-e251 (June 2015)

A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort.

Prevalence of and risk factors for active tuberculosis in migrants screened before entry to the UK: a population-based cross-sectional study Dr Robert.

Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries Dr Noreen.

Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study Krishna P Reddy,

Philippe Mayaud, MD, Sarah Hawkes, MB, Professor David Mabey, FRCP

Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis Gian Luca Di Tanna, PhD, Ali Raza Khaki,

Low-technology approaches

Thank you to our diverse (but not diverse enough) reviewers

Volume 16, Issue 1, Pages (January 2015)

Volume 392, Issue 10160, Pages (November 2018)

Genital herpes—how much of a public-health problem?

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

Volume 393, Issue 10177, Pages (March 2019)

Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review Alexander K Rowe,

Task sharing with non-physician health-care workers for management of blood pressure in low-income and middle-income countries: a systematic review and.

Jean H Humphrey, Andrew J Prendergast The Lancet Global Health

Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15 Prof Peter Lloyd-Sherlock,

Population attributable fractions for risk factors for dementia in low-income and middle- income countries: an analysis using cross-sectional survey data

Essay: Evidence-based health-care architecture

Harry E. Scher, DNP, APRN, Michelle L. Drew, DNP, FNP, Damon B

Economic decline, incarceration, and mortality from drug use disorders in the USA between 1983 and 2014: an observational analysis Elias Nosrati, PhD,

Sickle cell disease: a new era

Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling Gwenan M Knight, PhD, C Finn McQuaid,

Presentation transcript:

Drug-resistant tuberculosis: time for visionary political leadership Prof Ibrahim Abubakar, FRCP, Matteo Zignol, MD, Dennis Falzon, MD, Prof Mario Raviglione, FRCP, Lucica Ditiu, MD, Baroness Susan Masham, Ifedayo Adetifa, PhD, Nathan Ford, PhD, Helen Cox, PhD, Stephen D Lawn, FRCP, Ben J Marais, FCPaed, Prof Timothy D McHugh, PhD, Peter Mwaba, FRCP, Matthew Bates, PhD, Marc Lipman, FRCP, Prof Lynn Zijenah, PhD, Simon Logan, MSc, Ruth McNerney, PhD, Adam Zumla, MD, Krishna Sarda, MD, Payam Nahid, MD, Prof Michael Hoelscher, FRCP, Michel Pletschette, FRCP, Prof Ziad A Memish, FRCP, Peter Kim, MD, Richard Hafner, MD, Prof Stewart Cole, PhD, Prof Giovanni Battista Migliori, FRCP, Prof Markus Maeurer, FRCP, Marco Schito, PhD, Prof Alimuddin Zumla, FRCP The Lancet Infectious Diseases Volume 13, Issue 6, Pages 529-539 (June 2013) DOI: 10.1016/S1473-3099(13)70030-6 Copyright © 2013 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Terms and Conditions

Figure 1 Countries with at least one case of extensively drug-resistant tuberculosis by the end of 2011 Reproduced from WHO's global tuberculosis report 2012,2 by permission of the World Health Organization. The Lancet Infectious Diseases 2013 13, 529-539DOI: (10.1016/S1473-3099(13)70030-6) Copyright © 2013 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Terms and Conditions

Figure 2 Percentage of new tuberculosis cases with multidrug-resistant tuberculosis Based on the most recent year for which data have been reported, which varies among countries. Reproduced from WHO's global tuberculosis report 2012,2 by permission of the World Health Organization. The Lancet Infectious Diseases 2013 13, 529-539DOI: (10.1016/S1473-3099(13)70030-6) Copyright © 2013 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Terms and Conditions

Figure 3 Percentage of previously treated tuberculosis cases with multidrug-resistant tuberculosis *Based on the most recent year for which data have been reported, which varies among countries. Reproduced from WHO's global tuberculosis report 2012,2 by permission of the World Health Organization. The Lancet Infectious Diseases 2013 13, 529-539DOI: (10.1016/S1473-3099(13)70030-6) Copyright © 2013 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Terms and Conditions